Antitumor activity of IDN 5109, a new taxane, on human ovarian carcinoma xenografts

被引：0
|
作者：
Rossi, C
Mincione, T
Nicoletti, I
Bombardelli, E
Riva, A
Donati, MB
Giavazzi, R
机构：
[1] Consorzio Mario Negri Sud, Chieti, Italy
[2] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy
[3] Indena SPA, I-20141 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
349
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [31] IN-VIVO ANTITUMOR-ACTIVITY OF HEXAMETHYLMELAMINE AGAINST HUMAN BREAST, STOMACH AND COLON-CARCINOMA XENOGRAFTS
    TANINO, H
    KUBOTA, T
    YAMADA, Y
    KOH, J
    KASE, S
    FURUKAWA, T
    KUO, TH
    SAIKAWA, Y
    KITAJIMA, M
    NAITO, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (08): : 770 - 775
  • [32] Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts
    Previdi, Sara
    Malek, Anastasia
    Albertini, Veronica
    Riva, Cristina
    Capella, Carlo
    Broggini, Massimo
    Carbone, Giuseppina M.
    Rohr, Jurgen
    Catapano, Carlo V.
    GYNECOLOGIC ONCOLOGY, 2010, 118 (02) : 182 - 188
  • [33] Antitumor efficacy of panitumumab alone or with gemcitabine against human pancreatic carcinoma xenografts
    Freeman, D.
    Bush, T.
    Ogbagarbriel, S.
    Ziegler, B.
    Belmontes, B.
    Van, G.
    Johnson, C.
    Radinsky, R.
    ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
  • [34] Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft
    G Petrangolini
    G Cassinelli
    G Pratesi
    M Tortoreto
    E Favini
    R Supino
    C Lanzi
    S Belluco
    F Zunino
    British Journal of Cancer, 2004, 90 : 1464 - 1468
  • [35] The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma
    Cesca, Marta
    Frapolli, Roberta
    Berndt, Alexander
    Scarlato, Valentina
    Richter, Petra
    Kosmehl, Hartwig
    D'Incalci, Maurizio
    Ryan, Anderson J.
    Giavazzi, Raffaella
    NEOPLASIA, 2009, 11 (11): : 1155 - U59
  • [36] Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft
    Petrangolini, G
    Cassinelli, G
    Pratesi, G
    Tortoreto, M
    Favini, E
    Supino, R
    Lanzi, C
    Belluco, S
    Zunino, F
    BRITISH JOURNAL OF CANCER, 2004, 90 (07) : 1464 - 1468
  • [37] Antitumor effect of trimelamol against human breast carcinoma xenografts in nude mice
    Yamada, Y
    Kubota, T
    Hoshiya, Y
    Asanuma, F
    Koh, JI
    Kitajima, M
    Coley, HM
    Judson, IR
    ONCOLOGY REPORTS, 1996, 3 (04) : 613 - 617
  • [38] Antitumor Activity of a Novel Homodimeric SMAC Mimetic in Ovarian Carcinoma
    Gatti, Laura
    De Cesare, Michelandrea
    Ciusani, Emilio
    Corna, Elisabetta
    Arrighetti, Noemi
    Cominetti, Denis
    Belvisi, Laura
    Potenza, Donatella
    Moroni, Elisabetta
    Vasile, Francesca
    Lecis, Daniele
    Delia, Domenico
    Castiglioni, Vittoria
    Scanziani, Eugenio
    Seneci, Pierfausto
    Zaffaroni, Nadia
    Perego, Paola
    MOLECULAR PHARMACEUTICS, 2014, 11 (01) : 283 - 293
  • [39] Antitumor activity of lurbinectedin toward ovarian clear cell carcinoma
    Takahashi, Ryoko
    Mabuchi, Seiji
    Matsumoto, Yuri
    Kawano, Mahiru
    Sasano, Tomoyuki
    Kuroda, Hiromasa
    Kozasa, Katsumi
    Sawada, Kenjirou
    Kimura, Tadashi
    CANCER RESEARCH, 2015, 75
  • [40] Potentiation of antitumor activity of mitomycin C by estradiol: Studies of human breast carcinoma xenografts serially transplanted into nude mice
    Oka, S
    Kubota, T
    Takeuchi, T
    Kitajima, M
    JOURNAL OF SURGICAL ONCOLOGY, 1996, 61 (04) : 256 - 261
12345